Artificial Intelligence-Assisted Magnetic Resonance Imaging Diagnostic Strategy in a Tertiary Stroke Center
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAarhus University Hospital
About this trial
Quality improvement study with prospective observational design. The study monitors the diagnostic accuracy of an AI-assisted resident radiologist-termed the AI-ResRad diagnostic strategy-compared to an on-call specialist neuroradiologist-termed the SpecNeuroRad strategy-in interpreting stroke MRIs in patients with known onset.
The study includes a pre-planned sub-study evaluating the diagnostic accuracy of neurologists and AI-assisted neurologists.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Stroke team activation
Thrombolysis candidate
Known symptom onset
Disqualifiers
Prior inclusion
Previous MRI in the same course of hospitalization
No resident radiologist on call
Trial design
Treatments tested in this trial
- Index test (AI-ResRad)
- Reference test (SpecNeuroRad)
- Comparative Index tests: ResRad and AI-SpecNeuroRad
- Neurologist Diagnostic Accuracy (Sub-study outcome)
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov